Freeman, Jane
,
Vernon, Jonathan
Pilling, Sally
Morris, Kirsti
Nicolson, Scott
Shearman, Sharie
Clark, Emma
Palacios-Fabrega, Jose Alejandro
Wilcox, Mark
Funding for this research was provided by:
Astellas Pharma, Inc. (NA)
Article History
Received: 10 May 2019
Accepted: 11 September 2019
First Online: 7 December 2019
Compliance with ethical standards
:
: JF has received grants from Summit Therapeutics, Melinta and Morphochem.MHW has received grants and consultancy fees from Abbott, Actelion, Alere, Astellas, bioMerieux, Cerexa, Cubist, Da Volterra, the European Tissue Symposium, MedImmune, Optimer, Pfizer, Qiagen, Sanofi-Pasteur, Summit, Synthetic Biologics and Valneva and consultancy fees from Astra Zeneca, Basilea, Durata, The Medicine Company, Merck, Nabriva, Pfizer, Roche and Seres.JAPF is an employee of Astellas Pharma, Inc. and has a patent EP17167541.6 pending to Astellas Pharma Europe Ltd.All other authors have no conflict of interest to declare.
: This article does not contain any studies with human participants performed by any of the authors.
: Access to anonymised individual participant level data will not be provided for this trial as it meets one or more of the exceptions described on ExternalRef removed under “Sponsor Specific Details for Astellas.”